Rhythm Pharmaceuticals's total assets for Q2 2025 were $372.73M, a decrease of -3.61% from the previous quarter. RYTM total liabilities were $239.15M for the fiscal quarter, a 6.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.